Trial Site Detail
Drug: |
Sorafenib (Nexavar, BAY 43-9006) |
|||
|---|---|---|---|---|
Trial: |
Sorafenib in Treating Patients With Malignant Gastrointestinal Stromal Tumor That Progressed During or After Previous Treatment With Imatinib Mesylate and Sunitinib Malate |
|||
| Conditions: | Gastrointestinal Stromal Tumor | |||
Trial Status: |
Ongoing, but not recruiting |
|||
Central Illinois Hem/Onc319 E. Madison St. Ste F |
Principal Investigator: |
Edem Agamah, MD |
|---|---|
Contact: |
217-525-2500 |
Activation Status of this Site: |
Closed |
Notes about this Site: |
|
Central Illinois Hem/Onc Website: |
Navigating the Map
Use the plus (+) and minus (-) controls to zoom in/out.
Click and drag the map or use the arrows to move (pan) the map.
Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.